Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 12/20 | 0.52 |
| ▸ | OXTR | P30559 | 7/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.35 |
| ▸ | BUB1 | O43683 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6199880 | 1.00 | AVPR2 (0.52) | AVPR2OXTREPHX2UCHL1P2RX7 | |
| SCHEMBL6203853 | 0.82 | AVPR2 (0.50) | AVPR2OXTREPHX2P2RX7CYP2C9 | |
| SCHEMBL6202207 | 0.82 | AVPR2 (0.48) | AVPR2OXTREPHX2P2RX7CYP2C9 | |
| SCHEMBL6202917 | 0.82 | AVPR2 (0.48) | AVPR2OXTREPHX2P2RX7CYP2C9 | |
| SCHEMBL6221670 | 0.81 | AVPR2 (0.79) | AVPR2OXTR | |
| SCHEMBL5430909 | 0.81 | AVPR2 (0.79) | AVPR2OXTR | |
| SCHEMBL4198269 | 0.69 | AVPR2 (0.85) | AVPR2OXTR | |
| SCHEMBL4192208 | 0.67 | AVPR2 (0.64) | AVPR2OXTR | |
| SCHEMBL4198538 | 0.65 | AVPR2 (0.81) | AVPR2OXTR | |
| SCHEMBL6202921 | 0.63 | EPHX2 (0.37) | EPHX2P2RX7CYP2C9CYP2J2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1399436-B1 | OXYTOCIN AGONISTS | FERRING BV (NL) | 2005-03-16 | — | — | EP | disclosed |